Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy. (2017)
Attributed to:
Development of vascular homing peptides as a drug delivery system in pregnancy
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7150/thno.19678
PubMed Identifier: 29109771
Publication URI: http://europepmc.org/abstract/MED/29109771
Type: Journal Article/Review
Volume: 7
Parent Publication: Theranostics
Issue: 15
ISSN: 1838-7640